BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3732917)

  • 1. Choriocarcinoma associated with undetectable levels of human chorionic gonadotropin.
    Lemonnier MC; Glezerman M; Vauclair R; Audet-Lapointe P
    Gynecol Oncol; 1986 Sep; 25(1):48-52. PubMed ID: 3732917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine choriocarcinoma with negative specific serum radioimmunoassay for human chorionic gonadotropins.
    Bakri Y; Lee JH; Jahshan AE; Lewis GC
    Gynecol Oncol; 1982 Aug; 14(1):112-8. PubMed ID: 7201439
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
    Nishimura R; Ashitaka Y; Tojo S
    Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of hCG in choriocarcinoma using RIA kits for hCG and hCG-beta.
    Vlachová J; Růzková M; Jakoubková J; Skrivan J; Zavadil M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():166-71. PubMed ID: 6211046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary choriocarcinoma of the cervix].
    Abboud J; Attieh E; Afif N; Chalhoub S
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(2):149-51. PubMed ID: 7518853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
    Boyko WL; Russell HT
    Obstet Gynecol; 1979 Dec; 54(6):737-45. PubMed ID: 514561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of radioimmunoassay of serum human chorionic gonadotropin in the management of choriocarcinoma.
    Gupta SK; Buckshee K; Talwar GP
    J Assoc Physicians India; 1985 Feb; 33(2):144-7. PubMed ID: 2581931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells].
    Marth C; Madersbacher S; Herold M; Berger P; Hetzel H; Fuith LC; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):122-3. PubMed ID: 2318404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K; Uesato T; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.